Navkar Pharma-Packs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.93 M
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.18 Cr
About Navkar Pharma-Packs
Navkar Pharma-Packs Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 1994 and has a history of 30 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.93 M.
The company currently has active open charges totaling ₹2.18 Cr.
Naredra Vrajlal, Bhupendra Sanghvi, and Anil Vrajlal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74950MH1994PTC078511
-
Company No.
078511
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 1994
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Navkar Pharma-Packs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naredra Vrajlal
|
Director | 20-May-1994 | Current |
|
Bhupendra Sanghvi
|
Director | 20-May-1994 | Current |
|
Anil Vrajlal
|
Director | 20-May-1994 | Current |
Financial Performance of Navkar Pharma-Packs.
Navkar Pharma-Packs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navkar Pharma-Packs?
Unlock access to Navkar Pharma-Packs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹21.80 M
₹0
Charges Breakdown by Lending Institutions
- The Shamrao Vithal Co-Op. Bank Ltd : 2.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 1999 | The Shamrao Vithal Co-Op. Bank Ltd | ₹2.18 Cr | Open |
How Many Employees Work at Navkar Pharma-Packs?
Unlock and access historical data on people associated with Navkar Pharma-Packs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navkar Pharma-Packs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navkar Pharma-Packs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.